Clinical Trials
3 trialsNCT07593482 2026-05-18
FC-BALANCE
Swiss Cancer Institute
Phase 2 Not yet recruiting
NCT04792489 2025-04-24
DALY II USA/ MB-CART2019.1 for DLBCL
Miltenyi Biomedicine GmbH
Phase 2 Recruiting
NCT06415708 2024-05-16
Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Recruiting